1. Home
  2. CLDI vs FBGL Comparison

CLDI vs FBGL Comparison

Compare CLDI & FBGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

N/A

Current Price

$0.69

Market Cap

1.7M

Sector

Health Care

ML Signal

N/A

Logo FBS Global Limited Ordinary Shares

FBGL

FBS Global Limited Ordinary Shares

HOLD

Current Price

$2.29

Market Cap

3.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDI
FBGL
Founded
2014
1996
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.7M
3.0M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
CLDI
FBGL
Price
$0.69
$2.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 38.4K
21.5K
Earning Date
11-16-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $45,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.09
$0.33
52 Week High
$3.38
$4.30

Technical Indicators

Market Signals
Indicator
CLDI
FBGL
Relative Strength Index (RSI) 25.64 46.19
Support Level $0.62 $2.04
Resistance Level $1.29 $4.30
Average True Range (ATR) 0.06 0.21
MACD -0.00 -0.14
Stochastic Oscillator 7.41 15.15

Price Performance

Historical Comparison
CLDI
FBGL

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply, and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture, as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and sales of construction materials.

Share on Social Networks: